Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 2/20 | 0.63 |
| ▸ | RORC | P51449 | 9/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.59 |
| ▸ | MAPT | P10636 | 4/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.59 |
| ▸ | HBB | P68871 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | CASP1 | P29466 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29643208 | 1.00 | PTGER4 (0.63) | PTGER4RORCKDM4EMAPTALDH1A1 | |
| SCHEMBL21076080 | 0.92 | RORC (0.52) | PTGER4RORCKDM4EMAPTALDH1A1 | |
| SCHEMBL21599721 | 0.90 | PTGER4 (0.59) | PTGER4RORCKDM4EMAPTALDH1A1 | |
| SCHEMBL16119985 | 0.88 | ALDH1A1 (0.56) | PTGER4RORCKDM4EMAPTALDH1A1 | |
| SCHEMBL97588 | 0.85 | PTGER4 (0.54) | PTGER4RORC | |
| SCHEMBL17614522 | 0.85 | PTGER4 (0.53) | PTGER4RORCKDM4EMAPTALDH1A1 | |
| SCHEMBL18010701 | 0.84 | PTGER4 (0.52) | PTGER4RORCKDM4EMAPTALDH1A1 | |
| SCHEMBL18010711 | 0.84 | PTGER4 (0.52) | PTGER4RORCKDM4EMAPTALDH1A1 | |
| SCHEMBL1052731 | 0.84 | MAPT (0.59) | PTGER4RORCKDM4EMAPTALDH1A1 | |
| SCHEMBL1740131 | 0.84 | MAPT (0.59) | PTGER4RORCKDM4EMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-61218587-A | — | — | None | — | — | JP | disclosed |
| US-20160024083-A1 | COMPOUNDS AND METHODS FOR TREATING CANCERS | HEALTH RESEARCH, INC. (US) | 2016-01-28 | — | — | US | disclosed |
| WO-2014153043-A1 | COMPOUNDS AND METHODS FOR TREATING CANCERS | HEALTH RESEARCH, INC. (US) | 2014-09-25 | — | — | WO | disclosed |
| US-7060843-B1 | Electroluminescent devices comprising diketopyrrolopyrroles | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2006-06-13 | — | — | US | disclosed |
| US-7001677-B2 | Electroluminescent devices comprising diketopyrrolopyrroles | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2006-02-21 | — | — | US | disclosed |
| EP-1087005-B1 | Fluorescent diketopyrrolopyrroles | CIBA SC HOLDING AG (CH) | 2004-02-25 | — | — | EP | disclosed |
| US-20040009368-A1 | Electroluminescent devices comprising diketopyrrolopyrroles | OTANI JUNJI (JP) | 2004-01-15 | — | — | US | disclosed |
| EP-1087006-B1 | Electroluminescent devices comprising diketopyrrolopyrroles | CIBA SC HOLDING AG (CH) | 2003-10-15 | — | — | EP | disclosed |
| US-20030187106-A1 | Red, organge color; photostability, heat resistance | MORETTI ROBERT (CH) | 2003-10-02 | — | — | US | disclosed |
| US-6603020-B1 | Exhibiting a red or orange fluorescence | CIBA SPECIALTY CHEMICALS CORPORATION | 2003-08-05 | — | — | US | disclosed |
| EP-1329493-A2 | Electroluminescent devices comprising diketopyrrolopyrroles | Ciba SC Holding AG (CH) | 2003-07-23 | — | — | EP | disclosed |
| EP-1087005-A1 | Fluorescent diketopyrrolopyrroles | Ciba SC Holding AG (CH) | 2001-03-28 | — | — | EP | disclosed |
| EP-1087006-A1 | Electroluminescent devices comprising diketopyrrolopyrroles | Ciba SC Holding AG (CH) | 2001-03-28 | — | — | EP | disclosed |
| JP-S61218587-A | 5-(3-(9-ETHYL)CARBAZOLYL)TETRAZOLE AND ITS PRODUCTION | RICOH CO LTD | 1986-09-29 | — | — | JP | disclosed |
| US-4192677-A | ELECTROGRAPHIC CHARGE TRANSFER COMPOUNDS | RICOH CO., LTD. (JP) | 1980-03-11 | — | — | US | disclosed |
| US-4141729-A | 1,3,4-Oxadiazole derivatives and electrophotographic plates containing same | RICOH COMPANY, LTD. (JP) | 1979-02-27 | — | — | US | disclosed |
| US-4111850-A | CHARGE TRANSFER COMPLEX OF A FLUORENONE AND A CARBAZOLE | AMP INCORPORATED (US) | 1978-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030187106-A1 | Red, organge color; photostability, heat resistance | CBR1, CBR3, DPP8 | PTGER4 2735/4885RORC 209/4885KDM4E 2949/4885 |
| US-20160024083-A1 | COMPOUNDS AND METHODS FOR TREATING CANCERS | AR, KLK3, BRDT | PTGER4 838/4885RORC 119/4885KDM4E 1549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.